NASDAQ:GNVC - GenVec Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $7.1930 0.00 (0.00 %) (As of 11/18/2018 01:08 PM ET)Previous Close$7.1930Today's Range$7.1930 - $7.193052-Week Range$2.70 - $10.44VolumeN/AAverage Volume259,136 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email GenVec, Inc. (GenVec) is a clinical-stage biopharmaceutical company, engaged in the development of therapeutics and vaccines. The Company designs, tests and manufactures adenoviral-based product candidates. The Company's development programs address therapeutic areas, such as hearing loss and balance disorders, as well as vaccines against infectious diseases, including respiratory syncytial virus (RSV), herpes simplex virus (HSV), Enterovirus D68 (EV-D68) and malaria. In the area of animal health, it is developing vaccines against foot-and-mouth disease (FMD). The Company develops and commercializes its product candidates through collaborations. The Company's lead product candidate is CGF166. The Company's vaccine candidates include preventative vaccines against RSV and malaria, and a therapeutic vaccine for HSV. The Company is developing vaccine and anti-viral candidates for the prevention and containment of FMD outbreaks. Receive GNVC News and Ratings via Email Sign-up to receive the latest news and ratings for GNVC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryN/A SectorN/A Current SymbolNASDAQ:GNVC Previous Symbol CUSIPN/A Webwww.genvec.com Phone+1-240-6320740 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous Employees15 Outstanding SharesN/AMarket Cap$0.00 OptionableNot Optionable GenVec (NASDAQ:GNVC) Frequently Asked Questions What is GenVec's stock symbol? GenVec trades on the NASDAQ under the ticker symbol "GNVC." When did GenVec's stock split? How did GenVec's stock split work? GenVec's stock reverse split on Thursday, December 1st 2016. The 1-10 reverse split was announced on Wednesday, November 16th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, November 30th 2016. An investor that had 100 shares of GenVec stock prior to the reverse split would have 10 shares after the split. How were GenVec's earnings last quarter? GenVec Inc (NASDAQ:GNVC) issued its earnings results on Friday, November, 4th. The biopharmaceutical company reported ($0.05) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.08) by $0.03. The biopharmaceutical company had revenue of $0.17 million for the quarter, compared to analysts' expectations of $0.07 million. View GenVec's Earnings History. Has GenVec been receiving favorable news coverage? Media coverage about GNVC stock has trended positive on Sunday, InfoTrie Sentiment reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. GenVec earned a news sentiment score of 2.3 on InfoTrie's scale. They also assigned news headlines about the biopharmaceutical company a news buzz of 4.0 out of 10, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days. Who are GenVec's key executives? GenVec's management team includes the folowing people: Wayne T. Hockmeyer Ph.D., Independence Chairman of the BoardDouglas J. Swirsky, President, Chief Executive Officer, Corporate Secretary, DirectorWilliam N. Kelley M.D., Independent DirectorStefan D. Loren Ph.D., Independent DirectorQuinterol J. Mallette M.D., Independent DirectorMichael S. Richman, Independent DirectorMarc R. Schneebaum, Independent Director How do I buy shares of GenVec? Shares of GNVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is GenVec's stock price today? One share of GNVC stock can currently be purchased for approximately $7.1930. What is GenVec's official website? The official website for GenVec is http://www.genvec.com/. How can I contact GenVec? GenVec's mailing address is 910 Clopper Rd Ste 220n, GAITHERSBURG, MD 20878-1353, United States. The biopharmaceutical company can be reached via phone at +1-240-6320740. MarketBeat Community Rating for GenVec (NASDAQ GNVC)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 107 (Vote Outperform)Underperform Votes: 87 (Vote Underperform)Total Votes: 194MarketBeat's community ratings are surveys of what our community members think about GenVec and other stocks. Vote "Outperform" if you believe GNVC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GNVC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 11/18/2018 by MarketBeat.com StaffFeatured Article: What is a Stop Order?